p. 1−8
2008-2843
Vol.13/No.1
p. 9−18
2008-2843
Vol.13/No.1
200mg/dl). At first basal triglyceride and total cholesterol levels were determined in all patients. Then Patients were randomly received either lopid or gemfibrozil with a dose of 300mg BD (before breakfast and dinner) for one month and after re-maesuring the total serum triglyceride and cholesterol, their drug was changed to the other and treatment continued for another one month. During the treatment period patients were observed for the adverse effects and serum levels of cholesterol and triglyceride were determined at the end of the treatment again. Data were analyzed by using repeated measure tests and through SPSS 11 software. Results: Mean basal triglycride and cholesterol levels were respectively 342.30±73.67mg/dl and 206.25±37.79mg/dl. While both drugs caused significant reduction in serum level of triglyceride (P<0.001), they had no significant effect on cholesterol level (P>0.05). There was no significant difference between the two drugs in regard to their effects on serum levels of triglyceride and total cholesterol (P>0.05). Conclusion: Considering the same efficacy, gemfibrozil can be used instead of lopid in hyperlipedemic patients.]]>
p. 19−24
2008-2843
Vol.13/No.1
p. 25−32
2008-2843
Vol.13/No.1
p. 33−43
2008-2843
Vol.13/No.1
0.05) and histopathologic studies of livers showed no evidence of hepatotoxicity. Conclusion: The results suggest that decoction of E. amoenum has no hepatotoxicity.]]>
p. 44−54
2008-2843
Vol.13/No.1
p. 55−60
2008-2843
Vol.13/No.1
p. 61−69
2008-2843
Vol.13/No.1
p. 70−76
2008-2843
Vol.13/No.1
p. 77−81
2008-2843
Vol.13/No.1